ARTICLE | Company News
Deltagen, Lilly protein deal
August 2, 2001 7:00 AM UTC
Genomics play DGEN and Eli Lilly (LLY) will evaluate, develop and market therapeutic secreted proteins. LLY will provide potential targets from its secreted protein pipeline for Deltagen to evaluate i...